Closed-Loop insulin delivery during pregnancy in women with type 1 diabetes

New England Journal of Medicine

Volumn 375, Issue 7, 2016, Pages 644-654

  Stewart, Zoe A ^a   Wilinska, Malgorzata E ^a   Hartnell, Sara ^b   Temple, Rosemary C ^c   Rayman, Gerry ^f   Stanley, Katharine P ^d   Simmons, David ^b   Law, Graham R ^g   Scott, Eleanor M ^g   Hovorka, Roman ^a   Murphy, Helen R ^a,b,c,e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c Elsie Bertram Diabetes Centre   (United Kingdom)

^d DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

^e NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^f IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^g UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; LABOR; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PERINATAL PERIOD; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 1; METABOLISM; MULTICENTER STUDY; PREGNANCY IN DIABETICS;

ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 84982163223     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1602494     Document Type: Article

References (32)

1. Casson IF, Clarke CA, Howard CV, et al. Outcomes of pregnancy in insulin dependent diabetic women: Results of a five year population cohort study. BMJ 1997; 315: 275-8.
2. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 1991; 265: 731-6.
3. Confidential Enquiry into Maternal and Child Health (CEMACH). Diabetes in pregnancy: Are we providing the best care? Findings of a national enquiry: England, Wales and Northern Ireland. London: CEMACH, February 2007.
4. Middleton P, Crowther CA, Simmonds L. Different intensities of glycaemic control for pregnant women with pre-existing diabetes. Cochrane Database Syst Rev 2012; 8: CD008540.
5. National Pregnancy in Diabetes (NIPD) audit. West Yorkshire, United Kingdom: Health and Social Care Information Centre, 2015 (http://www.hscic.gov.uk/npid).
6. García-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: Three changes of direction. Diabetologia 2010; 53: 446-51.
7. Goudie RJ, Lunn D, Hovorka R, Murphy HR. Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: Every day is different. Diabetes Care 2014; 37(6): E121-2.
8. Murphy HR, Rayman G, Duffield K, et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 2007; 30: 2785-91.
9. Kerssen A, Evers IM, de Valk HW, Visser GH. Poor glucose control in women with type 1 diabetes mellitus and 'safe' hemoglobin A1c values in the first trimester of pregnancy. J Matern Fetal Neonatal Med 2003; 13: 309-13.
10. Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER. Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet Med 2012; 29: 558-66.
11. ter Braak EWMT, Evers IM, Willem Erkelens D, Visser GH. Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences. Diabetes Metab Res Rev 2002; 18: 96-105.
12. Evers IM, ter Braak EWMT, de Valk HW, van Der Schoot B, Janssen N, Visser GHA. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 2002; 25: 554-9.
13. Combs CA. Continuous glucose monitoring and insulin pump therapy for diabetes in pregnancy. J Matern Fetal Neonatal Med 2012; 25: 2025-7.
14. Kropff J, DeVries JH. Continuous glucose monitoring, future products, and update on worldwide artificial pancreas projects. Diabetes Technol Ther 2016; 18: Suppl2: S253-63.
15. Breton M, Farret A, Bruttomesso D, et al. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012; 61: 2230-7.
16. Hovorka R, Kumareswaran K, Harris J, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011; 342: d1855.
17. Hovorka R, Allen JM, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: A phase 2 randomised crossover trial. Lancet 2010; 375: 743-51.
18. Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014; 371: 313-25.
19. Kovatchev BP, Renard E, Cobelli C, et al. Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013; 36: 1851-8.
20. Dassau E, Zisser H, Harvey RA, et al. Clinical evaluation of a personalized artificial pancreas. Diabetes Care 2013; 36: 801-9.
21. Nimri R, Muller I, Atlas E, et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: Randomized crossover trial. Diabetes Care 2014; 37: 3025-32.
22. Ly TT, Roy A, Grosman B, et al. Day and night closed-loop control using the integrated Medtronic hybrid closed-loop system in type 1 diabetes at diabetes camp. Diabetes Care 2015; 38: 1205-11.
23. Thabit H, Tauschmann M, Allen JM, et al. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med 2015; 373: 2129-40.
24. Thabit H, Lubina-Solomon A, Stadler M, et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: A 4-week, multicentre, randomised crossover study. Lancet Diabetes Endocrinol 2014; 2: 701-9.
25. Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: A freeliving, randomized clinical trial. Diabetes Care 2014; 37: 1204-11.
26. Murphy HR, Elleri D, Allen JM, et al. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care 2011; 34: 406-11.
27. Murphy HR, Kumareswaran K, Elleri D, et al. Safety and efficacy of 24-h closedloop insulin delivery in well-controlled pregnant women with type 1 diabetes: A randomized crossover case series. Diabetes Care 2011; 34: 2527-9.
28. Murphy HR, Elleri D, Allen JM, et al. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia 2012; 55: 282-93.
29. Law GR, Ellison GT, Secher AL, et al. Analysis of continuous glucose monitoring in pregnant women with diabetes: distinct temporal patterns of glucose associated with large-for-gestationalage infants. Diabetes Care 2015; 38: 1319- 25.
30. Ramsay JO, Hooker G, Graves S. Functional data analysis with R and MATLAB. New York: Dordrecht Springer, 2009.
31. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995; 73: 17-24.
32. Desoye G, Nolan CJ. The fetal glucose steal: An underappreciated phenomenon in diabetic pregnancy. Diabetologia 2016; 59: 1089-94.